s6y
Company name or ticker
Search
ORAMED PHARMACEUTICALS INC.
8-K
Material agreement; Acquisition or sale completed
Filed
Tuesday, March 31, 2026
Period
Mar 25, 2026
Accession number
0001213900-26-037474
Documents
Current Report
8-K
Data files
3
Financial data and other files for software
101.SCH
XBRL Schema File
EX-101.SCH
101.LAB
XBRL Label File
EX-101.LAB
101.PRE
XBRL Presentation File
EX-101.PRE
On sec.gov
Filing index
All files
Complete submission text
SGML header